# Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)

> **NCT05291598** · PHASE3 · COMPLETED · sponsor: **University of Miami** · enrollment: 223 (actual)

## Conditions studied

- Total Knee Replacement
- Total Hip Replacement

## Interventions

- **DRUG:** IV meloxicam
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT05291598
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291598, "Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05291598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*